Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use

References

• Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114:409–414.
   PubMed Web of Science ®Google Scholar
• Merik PE, Plantae LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;395:2025–2033.
   Web of Science ®Google Scholar
• Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697–706.
   PubMed Web of Science ®Google Scholar
• James AH, Johnson MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality. Am J Obstet Gynecol 2006;194:1311–1315.
   PubMed Web of Science ®Google Scholar
• Rodger MA, Walker MC, Smith GN, et al. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study. J Thromb Haemost. 2014;12:469–478.
   PubMed Web of Science ®Google Scholar
• Scrifes CM, Macones GA. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction? Am J Obstet Gynecol. 2008;119:344.e1–.e7.
   Google Scholar
• Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9–13.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Inherited thrombophilias in pregnancy. Practice Bulletin. No. 138. 2013;122:706–717.
   Google Scholar
• Lykke JA, Bare LA, Olsen J, et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J Thromb Haemost. 2012;10:1320–1325.
   PubMed Web of Science ®Google Scholar
• Gat I, Dulitzki M, Schiff E, et al. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome. IMAJ. 2014; 16:96–100.
   Google Scholar
• Khalafallah AA, Ibraheem AO, Teo QY, et al. Review of management and outcomes in women with thrombophilia risk during pregnancy at a single institution. ISRN Obstet Gynecol. 2014;2014:381826.
   PubMedGoogle Scholar
• Alfirevic Z, Hata M, Martlew V, et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol. 2001;97:753–759.
   PubMed Web of Science ®Google Scholar
• Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy. Thrombosis. 2013;2013:516420.
   PubMedGoogle Scholar
• Tan WK, Lim SK, Tan LK, et al. Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review. Singapore Med J. 2012;53:695–663.
   Web of Science ®Google Scholar
• de Jong PG, Quenby S, Bloemenkamp KW, et al. ALIFE2 study: low molecular weight heparin for women with recurrent miscarriage and inherited thrombophilia – study protocol for a randomized controlled trial. Trials. 2015;16:208–218.
   PubMed Web of Science ®Google Scholar
• Rodger MA, Hague WM, Kingdom J, et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet. 2014;384:1673–1683.
   PubMed Web of Science ®Google Scholar
• West Virginia Health Rankings, 2013 [Accessed 2013 Jul 6]. Available from: http://www.americashealthrankings.org.
   Google Scholar
• Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. Pregnancy Risk Assessment Monitoring System [online], 2014 [cited 2015 Jul 08]. Available from: http://ncdd.cdc.gov/pramstat/.
   Google Scholar
• Cheng YJ, Liu ZH, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013; 10:e1001515. doi: 10.1371/journal.pmed.1001515.
   PubMed Web of Science ®Google Scholar
• Trust for America’s Health and Robert Wood Johnson Foundation. The State of Obesity [online]. Washington, D.C., 2014 [cited 2015 Jul 16]. Available from: http://stateofobesity.org/states/wv/.
   Google Scholar
• Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J Intern Med. 2015;277:573–584.
   PubMed Web of Science ®Google Scholar
• McColl MD, Ellison J, Reid F, et al. Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG. 2000;107:565–569.
   PubMed Web of Science ®Google Scholar
• Gris J, Mercier E, Quéré I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103:3695–3699.
   PubMed Web of Science ®Google Scholar
• Leeners B, Neumaier-Wagner P, et al. Smoking and the risk of developing hypertensive diseases in pregnancy: what is the effect on HELLP syndrome? Acta Obstet Gynecol Scand. 2006;85:1217–1224.
   PubMed Web of Science ®Google Scholar